Royal Bank of Canada reiterated their sector perform rating on shares of Kindred Healthcare, Inc. (NYSE:KND) in a report issued on Thursday morning. The firm currently has a $8.50 target price on the health services provider’s stock, up from their prior target price of $7.50.

Several other equities research analysts have also recently weighed in on the stock. ValuEngine upgraded shares of Kindred Healthcare from a sell rating to a hold rating in a research report on Thursday. Mizuho reiterated a neutral rating and set a $7.50 price objective (down from $8.00) on shares of Kindred Healthcare in a research report on Tuesday, October 10th. Zacks Investment Research cut shares of Kindred Healthcare from a hold rating to a sell rating in a research report on Tuesday, October 10th. Bank of America Corporation decreased their price objective on shares of Kindred Healthcare from $7.50 to $6.50 and set an underperform rating for the company in a research report on Thursday, September 21st. Finally, Deutsche Bank AG reiterated a hold rating and set a $9.00 price objective (down from $10.00) on shares of Kindred Healthcare in a research report on Monday, September 18th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of $9.17.

Kindred Healthcare (KND) traded down $0.20 on Thursday, hitting $7.50. 1,529,800 shares of the stock traded hands, compared to its average volume of 1,206,108. Kindred Healthcare has a 52 week low of $5.50 and a 52 week high of $11.90. The company has a debt-to-equity ratio of 6.22, a quick ratio of 1.49 and a current ratio of 1.55. The firm has a market capitalization of $669.38, a PE ratio of 38.50 and a beta of 1.12.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.19) by $0.08. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The company had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same period in the prior year, the company posted $0.05 earnings per share. Kindred Healthcare’s revenue for the quarter was down 5.5% compared to the same quarter last year. equities research analysts anticipate that Kindred Healthcare will post 0.27 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/11/kindred-healthcare-inc-knd-receives-sector-perform-rating-from-royal-bank-of-canada.html.

A number of hedge funds and other institutional investors have recently modified their holdings of KND. BlackRock Inc. boosted its stake in Kindred Healthcare by 41,968.4% during the first quarter. BlackRock Inc. now owns 10,779,191 shares of the health services provider’s stock worth $90,006,000 after acquiring an additional 10,753,568 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Kindred Healthcare by 69.8% during the third quarter. JPMorgan Chase & Co. now owns 3,572,684 shares of the health services provider’s stock worth $24,830,000 after acquiring an additional 1,468,066 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in Kindred Healthcare by 102.3% during the second quarter. Goldman Sachs Group Inc. now owns 1,753,787 shares of the health services provider’s stock worth $20,431,000 after acquiring an additional 886,906 shares in the last quarter. Vanguard Group Inc. boosted its stake in Kindred Healthcare by 8.6% during the second quarter. Vanguard Group Inc. now owns 8,031,919 shares of the health services provider’s stock worth $93,572,000 after acquiring an additional 635,000 shares in the last quarter. Finally, Bank of Nova Scotia boosted its stake in Kindred Healthcare by 232.3% during the second quarter. Bank of Nova Scotia now owns 876,317 shares of the health services provider’s stock worth $10,209,000 after acquiring an additional 612,598 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.